XENON PHARMACEUTICALS INC's ticker is and the CUSIP is 98420N905. A total of 2 filers reported holding XENON PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $1,536,206 | -84.8% | 39,400 | -83.2% | 0.01% | -84.6% |
Q1 2024 | $10,090,920 | +146.7% | 234,400 | +164.0% | 0.04% | +254.5% |
Q4 2023 | $4,090,128 | +523.6% | 88,800 | +362.5% | 0.01% | +450.0% |
Q3 2023 | $655,872 | -6.9% | 19,200 | +4.9% | 0.00% | 0.0% |
Q2 2023 | $704,550 | -51.6% | 18,300 | -55.0% | 0.00% | -60.0% |
Q1 2023 | $1,456,653 | +226.9% | 40,700 | +260.2% | 0.01% | +400.0% |
Q4 2022 | $445,559 | +11039.0% | 11,300 | +11200.0% | 0.00% | – |
Q3 2022 | $4,000 | -33.3% | 100 | -50.0% | 0.00% | – |
Q2 2022 | $6,000 | -90.6% | 200 | -90.5% | 0.00% | – |
Q1 2022 | $64,000 | -86.4% | 2,100 | -86.0% | 0.00% | – |
Q4 2021 | $469,000 | -69.3% | 15,000 | -85.0% | 0.00% | -100.0% |
Q3 2021 | $1,526,000 | +1856.4% | 99,900 | +2278.6% | 0.00% | – |
Q2 2021 | $78,000 | +4.0% | 4,200 | 0.0% | 0.00% | – |
Q1 2021 | $75,000 | +141.9% | 4,200 | +75.0% | 0.00% | – |
Q4 2019 | $31,000 | +3000.0% | 2,400 | +2300.0% | 0.00% | – |
Q3 2019 | $1,000 | 0.0% | 100 | 0.0% | 0.00% | – |
Q2 2019 | $1,000 | -83.3% | 100 | 0.0% | 0.00% | – |
Q4 2018 | $6,000 | – | 100 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GROUP ONE TRADING, L.P. | 100 | $1,000 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |